State legislative trends related to biomarker testing.

Sadigh, Gelareh; Goeckner, Hilary Gee; Kazerooni, Ella A; Johnson, Bruce E; Smith, Robert A; Adams, Devon V; Carlos, Ruth C

Sadigh, Gelareh; Goeckner, Hilary Gee; Kazerooni, Ella A; Johnson, Bruce E; Smith, Robert A; Adams, Devon V; Carlos, Ruth C.

Afiliação

Sadigh G; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
Goeckner HG; American Cancer Society Cancer Action Network, Inc, Washington, District of Columbia, USA.
Kazerooni EA; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Johnson BE; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Smith RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Adams DV; Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia, USA.
Carlos RC; American Cancer Society Cancer Action Network, Inc, Washington, District of Columbia, USA.

Cancer ; 128(15): 2865-2870, 2022 08 01.

Article em En | MEDLINE | ID: mdl-35607821

Assuntos

Gastos em Saúde; Cobertura do Seguro; Biomarcadores; Humanos; Illinois; Louisiana; Estados Unidos

Palavras-chave

biomarker testing; coverage; insurance; legislation; prior authorization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gastos em Saúde / Cobertura do Seguro Tipo de estudo: Guideline Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google